Binifibrate

Binifibrate

SCHEMBL29388376

CC(C)(Oc1ccc(Cl)cc1)C(=O)OC(COC(=O)c1cccnc1)COC(=O)c1cccnc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.51
▸ LMNA P02545 6/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ USP2 O75604 2/20 0.51
▸ CYP1A2 P05177 3/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ MAPT P10636 3/20 0.48
▸ TDP1 Q9NUW8 3/20 0.48
▸ ABCB11 O95342 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ HTR2A P28223 2/20 0.48
▸ PMP22 Q01453 2/20 0.48
▸ PPARA Q07869 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ CNR1 P21554 2/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADRB3 P13945 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Binifibrate SCHEMBL49116 1.00 KMT2A (0.51) KMT2ALMNAALDH1A1MEN1USP2
SCHEMBL22607962 0.90 ALDH1A1 (0.49) KMT2ALMNAALDH1A1MEN1USP2
SCHEMBL28434613 0.87 KMT2A (0.41) KMT2ALMNAALDH1A1MEN1USP2
Binifibrate SCHEMBL3959320 0.87 LMNA (0.52) KMT2ALMNAALDH1A1MEN1USP2
Etofibrate SCHEMBL29801484 0.85 L3MBTL1 (0.55) KMT2ALMNAALDH1A1MEN1USP2
Etofibrate SCHEMBL8168409 0.85 L3MBTL1 (0.55) KMT2ALMNAALDH1A1MEN1USP2
Etofibrate SCHEMBL3122 0.85 L3MBTL1 (0.55) KMT2ALMNAALDH1A1MEN1USP2
Etofibrate SCHEMBL1649349 0.84 L3MBTL1 (0.54) KMT2ALMNAALDH1A1MEN1USP2
Ronifibrate SCHEMBL48852 0.83 L3MBTL1 (0.59) KMT2ALMNAALDH1A1MEN1USP2
Simfibrate SCHEMBL5808862 0.83 L3MBTL1 (0.59) KMT2ALMNAALDH1A1MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113939288-B Modulators of MAS-related G protein receptor X4 and related products and methods 伊赛恩特制药公司 2025-04-25 — — CN disclosed
CN-115397412-B Modulators of MAS-related G protein receptor X4 and related products and methods 伊赛恩特制药公司 2025-03-25 — — CN disclosed
CN-118871595-A Improved diagnosis of nonalcoholic steatohepatitis 基恩菲特公司 2024-10-29 — — CN disclosed
CN-117915914-A Combination therapy for treating liver diseases 甘莱制药有限公司 2024-04-19 — — CN disclosed
CN-117915891-A Combination therapy for the treatment of liver diseases 甘莱制药有限公司 2024-04-19 — — CN disclosed
CN-117597327-A Pharmaceutical preparation 第一波动生物制药股份有限公司 2024-02-23 — — CN disclosed
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 — — US disclosed
Send feedback